The effect of inflammation and damage to lymph node structures on durable protective immunity following vaccination
炎症和淋巴结结构损伤对疫苗接种后持久保护性免疫力的影响
基本信息
- 批准号:10584503
- 负责人:
- 金额:$ 64.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-25 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAfricaAntibody ResponseAntibody titer measurementAntigensApoptosisArchitectureBCG LiveBacille Calmette-Guerin vaccinationBiological AssayBloodCD4 Lymphocyte CountCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCatalogsCell CountCellsCholeraChronicCollagenCytokine ActivationDataDenmarkDepositionDeveloped CountriesDeveloping CountriesDoseEnvironmental Risk FactorEthiopiaEuropeEuropeanExposure toFibrosisFrequenciesGeneticGeographyGut associated lymphoid tissueHIVHIV InfectionsHIV SeronegativityHelminthsHelper-Inducer T-LymphocyteHomeostasisHumanIL7 geneImmune responseImmunityImmunologic MarkersImmunologicsImpairmentIndividualInfectionInflammationInflammatoryInvestigationLaboratoriesLymphoid TissueMaintenanceMalariaMeasuresMediatingMinnesotaModelingMusMycobacterium tuberculosisPeripheral Blood Mononuclear CellPersonsPoliomyelitisPopulationPopulation StudyProcessProductionReactionRegulatory T-LymphocyteReticular CellRotavirusRotavirus VaccinesSalmonellaSourceStructureSwitzerlandT cell responseT-Cell DepletionT-LymphocyteT-Lymphocyte SubsetsTechniquesTestingThymus GlandTimeTissuesTropical ClimateTuberculosisUgandaVaccinatedVaccinationVaccinesVirus ReplicationWomanWorkYellow FeverYellow Fever Vaccinecohortcytokineexperimental studygeographic differenceimmune activationimmune functionlymph nodesmenmicrobialneutralizing antibodynovelpathogenpopulation basedresponsesample collectiontrendvaccination against tuberculosisvaccination outcomevaccine efficacyvaccine failurevaccine responsevaccine trial
项目摘要
Abstract
There are numerous examples of a vaccine that results in neutralizing antibodies in one population, but not
others. Rotavirus, polio, cholera, and tuberculosis (TB) are examples. BCG vaccination for TB has significantly
higher rates of protection the further north the vaccine is used. Reasons for differences in vaccine efficacy are
unknown with genetic or environmental factors thought to be important factors. An interesting parallel
observation is that population based measures of CD4 T cells also vary geographically, with people living in
northern latitudes having significantly greater numbers of CD4 T cells than people living close to the equator. In
our studies of mechanisms of loss of CD4 T cells in HIV infection, we showed that HIV replication in lymphoid
tissues caused inflammatory damage to the Fibroblastic Reticular Cell network (FRCn) in the form of collagen
deposition into the network. The FRCn is the primary source of IL-7 outside of the thymus and loss of the
network results in decreased production of IL-7 and the net result is increased T cell apoptosis. Our data
suggest this is a significant mechanism of CD4 loss in HIV infection. We speculated that infections other than
HIV might cause inflammatory damage to the FRCn and might be a reason CD4 T cells are depleted in
populations of people living in tropical climates, especially developing economies. This may be a factor in
limiting vaccine responses in these populations. We studied lymph nodes in HIV negative people living in
Uganda and show in our preliminary data that the FRCn and CD4 T cell populations are depleted and that
levels of inflammatory cytokines and tissue markers of immune activation are elevated. We vaccinated them
with yellow fever vaccine (YFV) and found the peak neutralizing antibody titer correlated to our quantitative
analyses of the FRCn and measures of inflammatory cytokines and immune activation. These data support our
model of inflammatory damage to the architecture of lymph nodes as a contributing factor to failure of vaccine
efficacy in the developing world. We now propose to build on these preliminary studies by giving YFV to a
larger cohort of Ugandans but also to add a cohort in Minnesota where we have shown limited inflammatory
damage to the FRCn. We will conduct extensive immunologic and microbial investigations of factors that limit
durable immune responses. Our hypothesis is that endemic infections other than HIV can cause LN
inflammation and collagen damage to the FRCn which will lead to CD4 T cell depletion and impaired vaccine
responses.
摘要
有许多疫苗在一个人群中产生中和抗体的例子,但不是
其他。轮状病毒、小儿麻痹症、霍乱和结核病就是例子。卡介苗对结核病的预防效果显著
疫苗使用得越靠北,保护率就越高。疫苗效力不同的原因是
未知的,遗传或环境因素被认为是重要因素。一个有趣的类比
观察到,基于人群的CD4T细胞测量方法也因地域而异,人们生活在
北纬地区的CD4T细胞数量比生活在赤道附近的人多得多。在……里面
我们对HIV感染中CD4T细胞丢失机制的研究表明,HIV在淋巴中复制
组织以胶原的形式对成纤维细胞网状细胞网络(FRCN)造成炎性损害
录入网络的证据。FRCN是胸腺外IL-7的主要来源,
网络导致IL-7的产生减少,最终结果是T细胞凋亡增加。我们的数据
提示这是HIV感染中CD4丢失的一个重要机制。我们推测,除了
HIV可能会对FRCN造成炎性损害,这可能是CD4T细胞耗尽的一个原因
生活在热带气候,特别是发展中经济体的人口。这可能是一个因素
限制这些人群的疫苗反应。我们研究了生活在艾滋病病毒阴性人群中的淋巴结
并在我们的初步数据中显示,FRCN和CD4T细胞群已经枯竭,
炎性细胞因子和免疫激活的组织标志物水平升高。我们给他们接种了疫苗
与黄热病疫苗(YFV),发现峰值中和抗体滴度与我们的定量
FRCN的分析及炎性细胞因子和免疫激活的测定。这些数据支持我们的
作为疫苗失败诱因的淋巴结炎性损伤模型
发展中世界的功效。我们现在建议在这些初步研究的基础上,将YFV给予
更大的乌干达人队列,但也增加了明尼苏达州的队列,在那里我们显示出有限的炎症
对FRCN的破坏。我们将对限制因素进行广泛的免疫学和微生物调查
持久的免疫反应。我们的假设是,除艾滋病毒以外的地方性感染可导致LN
FRCN的炎症和胶原损伤将导致CD4T细胞耗尽和疫苗受损
回应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy W Schacker其他文献
Timothy W Schacker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy W Schacker', 18)}}的其他基金
Investigation of persistent HIV immune stimulation in lymphoid tissues during therapy as a cause of sustained immune activation
研究治疗期间淋巴组织中持续的 HIV 免疫刺激作为持续免疫激活的原因
- 批准号:
10598469 - 财政年份:2020
- 资助金额:
$ 64.97万 - 项目类别:
Investigation of persistent HIV immune stimulation in lymphoid tissues during therapy as a cause of sustained immune activation
研究治疗期间淋巴组织中持续的 HIV 免疫刺激作为持续免疫激活的原因
- 批准号:
10011279 - 财政年份:2020
- 资助金额:
$ 64.97万 - 项目类别:
Investigation of persistent HIV immune stimulation in lymphoid tissues during therapy as a cause of sustained immune activation
研究治疗期间淋巴组织中持续的 HIV 免疫刺激作为持续免疫激活的原因
- 批准号:
10376189 - 财政年份:2020
- 资助金额:
$ 64.97万 - 项目类别:
The effect of inflammation and damage to lymph node structures on durable protective immunity following vaccination
炎症和淋巴结结构损伤对疫苗接种后持久保护性免疫力的影响
- 批准号:
10091395 - 财政年份:2019
- 资助金额:
$ 64.97万 - 项目类别:
The effect of inflammation and damage to lymph node structures on durable protective immunity following vaccination
炎症和淋巴结结构损伤对疫苗接种后持久保护性免疫力的影响
- 批准号:
10335121 - 财政年份:2019
- 资助金额:
$ 64.97万 - 项目类别:
Reservoir Dynamics in Patients Treated in Very Early Acute HIV Infection
极早期急性 HIV 感染患者的储库动态
- 批准号:
9305845 - 财政年份:2016
- 资助金额:
$ 64.97万 - 项目类别:
Reservoir Dynamics in Patients Treated in Very Early Acute HIV Infection
极早期急性 HIV 感染患者的储库动态
- 批准号:
9203883 - 财政年份:2016
- 资助金额:
$ 64.97万 - 项目类别:
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
逆转组织纤维化以改善艾滋病毒的免疫重建
- 批准号:
8509163 - 财政年份:2013
- 资助金额:
$ 64.97万 - 项目类别:
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
逆转组织纤维化以改善艾滋病毒的免疫重建
- 批准号:
8617223 - 财政年份:2013
- 资助金额:
$ 64.97万 - 项目类别:
相似海外基金
Multi-component interventions to reducing unhealthy diets and physical inactivity among adolescents and youth in sub-Saharan Africa (Generation H)
采取多方干预措施减少撒哈拉以南非洲青少年的不健康饮食和缺乏身体活动(H 代)
- 批准号:
10106976 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
EU-Funded
Exploring the mental health and wellbeing of adolescent parent families affected by HIV in South Africa
探讨南非受艾滋病毒影响的青少年父母家庭的心理健康和福祉
- 批准号:
ES/Y00860X/1 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Fellowship
Decolonization, Appropriation and the Materials of Literature in Africa and its Diaspora
非洲及其侨民的非殖民化、挪用和文学材料
- 批准号:
EP/Y024516/1 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
Exploring "Actionable Information" for Learning Improvement in Rural East Africa: A Positive Deviance Approach
探索东非农村地区学习改进的“可行信息”:积极偏差方法
- 批准号:
24K00390 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ePowerCart - Affordable Mobile Clean Energy for Remote Communities in Rural Sub-Saharan Africa and India
ePowerCart - 为撒哈拉以南非洲和印度农村偏远社区提供经济实惠的移动清洁能源
- 批准号:
10076185 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Collaborative R&D
Protecting Women from Economic shocks to fight HIV in Africa (POWER)
保护非洲妇女免受经济冲击,抗击艾滋病毒 (POWER)
- 批准号:
MR/Y003837/1 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Fellowship
Tackling antimicrobial resistance across dentistry in Sub-Saharan Africa.
解决撒哈拉以南非洲牙科领域的抗菌素耐药性问题。
- 批准号:
MR/Y019695/1 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
Water stressed cities: individual choice, access to water and pathways to resilience in sub-Saharan Africa
缺水城市:撒哈拉以南非洲地区的个人选择、水资源获取和恢复力途径
- 批准号:
MR/X022943/1 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Fellowship
The Open fracture National Evaluation (ONE) Study - South Africa: Improving outcomes in the care of open fractures in low resource settings
开放性骨折国家评估 (ONE) 研究 - 南非:改善资源匮乏地区开放性骨折的护理效果
- 批准号:
MR/Y00955X/1 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Fellowship
Recognising & supporting informal mhealth in Africa through grassroots interventions (REIMAGINE)
认识
- 批准号:
MR/Y015614/1 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant